g6pd-mangel
Portal
/
Laegehaandbogen
/
blod
/
tilstande-og-sygdomme
/
anaemier
/
g6pd-mangel
/
Home
Data
patienthaandbogen
Sundheddk apps
Laegehaandbogen
Klinikpersonale
akut-og-foerstehjaelp
allergi
arbejdsmedicin
blod
symptomer-og-tegn
tilstande-og-sygdomme
anaemier
anaemi-ved-kronisk-sygdom
aplastisk-anaemi
folsyremangel
g6pd-mangel
haemolytiske-anaemier
jernmangelanaemi
jernmangelanaemi-hos-boern
seglcelleanaemi
talassaemi
vitamin-b12-mangel
blodpladesygdom
koagulationsforstyrrelser
leukaemier
lymfomer
oevrige-sygdomme
behandlinger
porfyrier
knoglemarvssygdom
undersoegelser
patientinformation
illustrationer
brystsygdomme
boern-og-unge
boerne-og-ungdomspsykiatri
endokrinologi
forsikringsmedicin
fysmed-og-rehab
generelt
geriatri
gynaekologi
hjerte-kar
hud
infektioner
kirurgi
kraeft
lunger
mandlige-koensorganer
mave-tarm
neurologi
nyrer-og-urinveje
obstetrik
ortopaedi
psykiatri
paediatri
rejsemedicin-vacciner
reumatologi
sexsygdomme
sjaeldne-sygdomme
socialmedicin
oeje
oere-naese-hals
sundhedsoplysning
undersoegelser-og-proever
om-laegehaandbogen
soeg
dli-medicin
Apps
Brugermanual
<Provider Id="sundheddkcms"> <Item Id="{5FC9F7E7-4E62-4C68-B8AC-432CB495EBBA}" Name="g6pd-mangel" Type="LHContentPage" ParentProviderId="sundheddkcms" ParentItemId="{679CED2A-382C-4F25-9AEF-CC1C7340FC92}" SortOrder="400" PublishDate="2010-06-23T10:39:00" DeleteDate="2999-12-31T00:00:00" PotItemType=""> <Content> <HtmlField Name="PageContent"><![CDATA[<h2>Diagnose</h2> <h3>Diagnostiske kriterier</h3> <ul> <li>Diagnosen stilles ved en kvantitativ spektrofotometrisk analyse, eller hyppigere ved hjælp af en hurtigtest som giver fluorescens, når NADPH dannes fra NADP<a href="%20" title="Gregg XT, Prchal JT. Red cell enzymopathies. In: Hoffman R, ed. Hematology: basic principles and practice. 4th ed. Philadelphia: Churchill Livingstone; 2000; 657-60" data-url="reference-link" data-value-piped="Gregg XT, Prchal JT|Red cell enzymopathies. In: Hoffman R, ed. Hematology: basic principles and practice. 4th ed| Philadelphia|Churchill Livingstone|2000; 657-60" data-value="Gregg XT, Prchal JT. Red cell enzymopathies. In: Hoffman R, ed. Hematology: basic principles and practice. 4th ed. Philadelphia: Churchill Livingstone; 2000; 657-60" data-type="book-reference"><sup>1</sup></a>, dvs en enzymaktivitetsmåling. Genundersøgelse kan også udføres men kræver sekventering af genet, hvor der er beskrevet mere end 200 forskellige mutationer. </li> </ul> <h3>Sygehistorie</h3> <ul> <li>Da tilstanden er medfødt, bør den mistænkes hos børn med en familiehistorie med gulsot, anæmi, splenomegali eller galdesten, særligt hvis barnet stammer fra Afrika, Asien eller Middelhavslandene<a href="%20" title="Hermiston ML, Mentzer WC, A practical approach to the evaluation of the anemic child. Pediatr Clin North Am 2002;49: 877-91" data-url="reference-link" data-value-piped="Hermiston ML, Mentzer WC|A practical approach to the evaluation of the anemic child|Pediatr Clin North Am|2002|49|877-91" data-value="Hermiston ML, Mentzer WC, A practical approach to the evaluation of the anemic child. Pediatr Clin North Am 2002;49: 877-91" data-type="journal-reference"><sup>2</sup></a></li> <li>Idet sygdommen nedarves X bundet, er den hyppigst hos drengebørn, men i højendemiske områder kan G6PD mangel også ses hos kvinder</li> </ul> <h3>Supplerende undersøgelser</h3> <ul> <li>Fluorescerende hurtigtest <ul> <li>Påviser dannelse af NADPH fra NADP</li> <li>Testen er positiv, hvis blodpletten ikke fluorescerer under ultraviolet lys</li> </ul> </li> <li>Der findes også andre tests, som er mere egnede til screening i risikopopulationer<a href="%20" title="Jalloh A, Tantular IS, Pusarawati S, Kawilarang AP, Kerong H, Lin K, et al, Rapid epidemiologic assessment of glucose-6-phosphate dehydrogenase deficiency in malaria-endemic areas in Southeast Asia using a novel diagnostic kit. Trop Med Int Health 2004;9: 615-23" data-url="reference-link" data-value-piped="Jalloh A, Tantular IS, Pusarawati S, Kawilarang AP, Kerong H, Lin K, et al|Rapid epidemiologic assessment of glucose-6-phosphate dehydrogenase deficiency in malaria-endemic areas in Southeast Asia using a novel diagnostic kit|Trop Med Int Health|2004|9|615-23" data-value="Jalloh A, Tantular IS, Pusarawati S, Kawilarang AP, Kerong H, Lin K, et al, Rapid epidemiologic assessment of glucose-6-phosphate dehydrogenase deficiency in malaria-endemic areas in Southeast Asia using a novel diagnostic kit. Trop Med Int Health 2004;9: 615-23" data-type="journal-reference"><sup>3</sup></a>, og PCR-tests kan påvise specifikke mutationer</li> <li>Begrænsninger i testene <ul> <li>Hos patienter med akut hæmolyse kan testning på G6PD-mangel give falskt negativt resultat, fordi ældre erytrocytter med lavest enzymaktivitet er hæmolyserede, mens yngre erytrocytter og retikulocytter har normal eller nær normal enzymaktivitet. Risikoen for falsk negativ resultat øges også såfremt der indenfor de sidste 30 dage er givet blodtransfusion. </li> <li>Heterozygote kvinder kan være vanskelige at diagnosticere</li> </ul> </li> <li>Indikationer for testning <ul> <li>Bør vurderes hos børn eller voksne (særligt mænd fra Afrika, Middelhavslande eller Asien) med en akut hæmolytisk reaktion udløst af infektion, eksponering for kendt oxidiativ medicin eller indtag af favabønner</li> <li>I enkelte endemiske områder af verden foretages screening af nyfødte</li> <li>Ved planlagt behandling med lægemidler, som indebærer høj risiko for hæmolytisk krise, anbefales testning for G6PD mangel optimalt, inden behandling med lægemidlet påbegyndes (f.eks. Primaquin for P. Vivax Malaria, eller Rasburicase som tumorlyseprofylakse)</li> </ul> </li> </ul> <h4>Neonatal hyperbilirubinæmi</h4> <ul> <li>Prævalens er dobbelt så høj som i den generelle befolkning hos drenge, som bærer det defekte gen og blandt homozygote piger</li> <li>Tilstanden forekommer sjældent hos heterozygote piger</li> <li>Man kender ikke fuldt ud til mekanismen bag neonatal hyperbilirubinæmi, forklaringen er ikke udelukkende hæmolyse<a href=" " data-type="journal-reference" data-value="Bizzarro MJ, Colson E, Ehrenkranz RA, Differential diagnosis and management of anemia in the newborn. Pediatr Clin North Am 2004;51: 1087-107, xi" data-value-piped="Bizzarro MJ, Colson E, Ehrenkranz RA|Differential diagnosis and management of anemia in the newborn.|Pediatr Clin North Am|2004|51|1087-107, xi|15275990" data-url="reference-link" data-pubmedid="15275990" title="Bizzarro MJ, Colson E, Ehrenkranz RA, Differential diagnosis and management of anemia in the newborn. Pediatr Clin North Am 2004;51: 1087-107, xi"><sup>4</sup></a></li> <li>G6PD-mangel bør mistænkes hos nyfødte, som udvikler hyperbilirubinæmi i løbet de første 24 timer, hvor en søskende har haft gulsot, bilirubinværdien er højere end 95-percentilen og blandt asiatiske drenge<a href=" " data-type="journal-reference" data-value="American Academy of Pediatrics Subcommittee on Hyperbilirubinemia., Management of hyperbilirubinemia in the newborn infant 35 or more weeks of gestation. Pediatrics 2004;114: 297-316" data-value-piped="American Academy of Pediatrics Subcommittee on Hyperbilirubinemia.|Management of hyperbilirubinemia in the newborn infant 35 or more weeks of gestation.|Pediatrics|2004|114|297-316|15231951" data-url="reference-link" data-pubmedid="15231951" title="American Academy of Pediatrics Subcommittee on Hyperbilirubinemia., Management of hyperbilirubinemia in the newborn infant 35 or more weeks of gestation. Pediatrics 2004;114: 297-316"><sup>5</sup></a></li> <li>G6PD-mangel kan øge risikoen for og medføre tidligere debut af hyperbilirubinæmi, hvilket kan kræve fototerapi eller udskiftningstransfusion</li> <li>I visse populationer kan hyperbilirubinæmien blive så alvorlig, at det øger risikoen for kernicterus og død<a href="%20" title="Nair PA, Al Khusaiby SM, Kernicterus and G6PD deficiency-a case series from Oman. J Trop Pediatr 2003;49: 74-7" data-url="reference-link" data-value-piped="Nair PA, Al Khusaiby SM|Kernicterus and G6PD deficiency-a case series from Oman|J Trop Pediatr|2003|49|74-7" data-value="Nair PA, Al Khusaiby SM, Kernicterus and G6PD deficiency-a case series from Oman. J Trop Pediatr 2003;49: 74-7" data-type="journal-reference"><sup>6</sup></a>, mens dette ikke er tilfældet i andre populationer<a href="%20" title="Kaplan M, Vreman HJ, Hammerman C, Leiter C, Abramov A, Stevenson DK, Contribution of haemolysis to jaundice in Sephardic Jewish glucose-6-phosphate dehydrogenase deficient neonates. Br J Haematol 1996;93: 822-7" data-url="reference-link" data-value-piped="Kaplan M, Vreman HJ, Hammerman C, Leiter C, Abramov A, Stevenson DK|Contribution of haemolysis to jaundice in Sephardic Jewish glucose-6-phosphate dehydrogenase deficient neonates|Br J Haematol|1996|93|822-7" data-value="Kaplan M, Vreman HJ, Hammerman C, Leiter C, Abramov A, Stevenson DK, Contribution of haemolysis to jaundice in Sephardic Jewish glucose-6-phosphate dehydrogenase deficient neonates. Br J Haematol 1996;93: 822-7" data-type="journal-reference"><sup>7</sup></a></li> </ul> <h4>Akut hæmolyse</h4> <ul> <li>Skyldes infektion (hyppigst), indtag af favabønner eller eksponering for oxidativt medikament</li> <li>Eksempler på medikamenter, som bør undgås, er dapson, flutamid, ciprofloxacin, nitrofurantoin, primaquin, sulfamethoxazol, rasburicase<a href=" " data-type="journal-reference" data-value="Bizzarro MJ, Colson E, Ehrenkranz RA, Differential diagnosis and management of anemia in the newborn. Pediatr Clin North Am 2004;51: 1087-107, xi" data-value-piped="Bizzarro MJ, Colson E, Ehrenkranz RA|Differential diagnosis and management of anemia in the newborn.|Pediatr Clin North Am|2004|51|1087-107, xi|15275990" data-url="reference-link" data-pubmedid="15275990" title="Bizzarro MJ, Colson E, Ehrenkranz RA, Differential diagnosis and management of anemia in the newborn. Pediatr Clin North Am 2004;51: 1087-107, xi"><sup>4</sup></a></li> <li>Hæmolysen optræder efter eksponering for den udløsende faktor, men fortsætter ikke trods infektion eller fortsat medikamentindtagelse. Dette skyldes formentlig, at de ældste erytrocytter har højest enzymmangel og bliver hæmolyseret først, mens de tilbageværende yngre erytrocytter med højere enzymaktivitet kan modstå den oxidative skade</li> <li>Klinisk kan tilstanden give ryg- og mavesmerter samt ikterus sekundært til stigning i mængden af ukonjugeret bilirubin</li> <li>Ved normal leverfunktion opstår ikterus først, når mere end 50% af erytrocytterne er blevet hæmolyseret</li> <li>Hæmolyse indtræder 24-72 timer efter medikamentindtagelse og remitterer i løbet af 4-7 dage</li> <li>Hæmolysen er intravaskulær og medfører foruden ikterus hæmoglobinuri, risiko for nyresvigt og blodpropper samt i alvorlige tilfælde, livstruende hæmolytisk anæmi</li> </ul> <h4>Kronisk hæmolyse</h4> <ul> <li>Ved kronisk ikke-sfærocytisk hæmolytisk anæmi, som sædvanligvis skyldes en sporadisk genmutation, optræder hæmolyse i forbindelse med normal erytrocytmetabolisme<a href=" " data-type="journal-reference" data-value="Bizzarro MJ, Colson E, Ehrenkranz RA, Differential diagnosis and management of anemia in the newborn. Pediatr Clin North Am 2004;51: 1087-107, xi" data-value-piped="Bizzarro MJ, Colson E, Ehrenkranz RA|Differential diagnosis and management of anemia in the newborn.|Pediatr Clin North Am|2004|51|1087-107, xi|15275990" data-url="reference-link" data-pubmedid="15275990" title="Bizzarro MJ, Colson E, Ehrenkranz RA, Differential diagnosis and management of anemia in the newborn. Pediatr Clin North Am 2004;51: 1087-107, xi"><sup>4</sup></a></li> <li>Sværhedsgraden af hæmolysen varierer og kan give fra mild hæmolyse til transfusionskrævende anæmi</li> <li>Eksponering for oxidativt stress kan forårsage akut hæmolyse hos disse personer</li> </ul> <h3>Andre undersøgelser hos specialist eller undersøgelse på sygehus</h3> <ul> <li>DAT test ( direkte antiglobulin test) er negativ. </li> <li>Normalt vil der blive foretaget mikroskopi af perifert blodudstryg. Her kan påvises Heinz legemer ved specialfarvninger, som er kondenseret denatureret methæmoglobin, der ofte siden fjernes af makrofager i milten, hvilket efterlader erytrocytter med karakteristiske membranskader (såkaldte bite cells)</li> <li>Knoglemarvsundersøgelse er som regel ikke nødvendig</li> <li>UL abdomen kan vise let splenomegali</li> <li>Enzymtest kan bekræfte diagnosen</li> <li>I visse tilfælde udføres DNA test</li> </ul> <h3>Differentialdiagnoser</h3> <ul> <li>Andre hæmolytiske anæmier</li> </ul> <h2>Behandling</h2> <h3>Behandlingsmål</h3> <ul> <li>Undgå lægemidler og fødemidler med kendt risiko for at udløse hæmolytiske kriser. En fyldestgørende liste <a rel="noopener noreferrer" href="https://www.g6pd.org/en/G6PDDeficiency/SafeUnsafe/DaEvitare_ISS-it" target="_blank">kan findes her</a></li> </ul> <h3>Generelt om behandlingen</h3> <ul> <li>Hovedbehandlingen er at undgå oxidative "stressorer"</li> <li>Undtagelsesvis kan anæmien blive så alvorlig, at det kræver blodtransfusion. Ved svær hæmolytisk krise er patienten indlagt - der kan være behov for såvel større blodtransfusion, understøttelse af nyrefunktion og behandling af udløsende årsag (f.eks. infektion)</li> <li>Splenektomi anbefales sædvanligvis ikke</li> </ul> <h3>Håndtering i almen praksis</h3> <ul> <li>Patient med kendt G6PD mangel bør gøres bekendt med arvegang, og andre familiemedlemmer kan tilbydes henvisning til udredning. Ligeledes er det vigtigt, at patienten kender til hvilke lægemidler og fødemidler som bør undgås (se ovennævnte link) </li> </ul> <h3>Råd til patienten</h3> <ul> <li>Afholde sig fra indtagelse af favabønner, visse andre fødemidler samt lægemidler som udgør risiko for hæmolytiske kriser</li> </ul> <h3>Medicinsk behandling</h3> <ul> <li>[DliActiveSubstance;5342;Folsyre] og jerntilskud kan være nyttig ved kronisk hæmolyse, men vanligvis er G6PD-mangel asymptomatisk og evt. hæmolyse er kortvarig</li> <li>Antioxidanter som vitamin E og selen har ikke vist sig nyttig ved G6PD-mangel<a href=" " data-type="journal-reference" data-value="Bizzarro MJ, Colson E, Ehrenkranz RA, Differential diagnosis and management of anemia in the newborn. Pediatr Clin North Am 2004;51: 1087-107, xi" data-value-piped="Bizzarro MJ, Colson E, Ehrenkranz RA|Differential diagnosis and management of anemia in the newborn.|Pediatr Clin North Am|2004|51|1087-107, xi|15275990" data-url="reference-link" data-pubmedid="15275990" title="Bizzarro MJ, Colson E, Ehrenkranz RA, Differential diagnosis and management of anemia in the newborn. Pediatr Clin North Am 2004;51: 1087-107, xi"><sup>4</sup></a></li> </ul> <h2>Henvisning</h2> <ul> <li>Ved mistanke om tilstanden</li> </ul> <h2>Opfølgning</h2> <ul> <li>Tilstanden kræver sædvanligvis ikke opfølgning, medmindre det drejer sig om de kroniske non-sfærocytotiske hæmolytiske tilstande, som er sjældne. Øvrige tilfælde vil ofte ikke have kronisk hæmolyse, men kun ved eksposition, som derved bør være bekendt for patienten og skal undgås</li> </ul> <h2>Sygdomsforløb, komplikationer og prognose</h2> <h3>Sygdomsforløb</h3> <ul> <li>Såfremt man følger forholdsregler vil der ofte ikke være problemer med sværere hæmolysetilfælde. Der kan være tidlig og mere træg ikterus efter fødslen, som kan kræve lysbehandling og i visse tilfælde udskiftningstransfusion</li> </ul> <h3>Komplikationer</h3> <ul> <li>Opstår primært ved svær hæmolytisk krise, som hvis ikke erkendt og behandlet kan medføre alvorlig og livstruende intravaskulær hæmolyse med svær anæmi og evt. nyresvigt og tromboser</li> </ul> <h3>Prognose</h3> <ul> <li>God. De fleste bærere lever et helt normalt liv, så længe de tager deres forholdsregler</li> </ul> <h2>Baggrundsoplysninger</h2> <h3>Definition</h3> <ul> <li>Glucose-6-phosphate dehydrogenase (G6PD) mangel er en medfødt hæmolytisk anæmi</li> <li>Det er en tilstand, som øger erytrocytternes sårbarhed overfor oxidativt stress<a href=" " data-type="journal-reference" data-value="Frank JE, Diagnosis and management of G6PD deficiency. Am Fam Physician 2005;72: 1277-82" data-value-piped="Frank JE|Diagnosis and management of G6PD deficiency.|Am Fam Physician|2005|72|1277-82|16225031" data-url="reference-link" data-pubmedid="16225031" title="Frank JE, Diagnosis and management of G6PD deficiency. Am Fam Physician 2005;72: 1277-82"><sup>8</sup></a> </li> <li>Klinisk præsenterer tilstanden sig som akut hæmolytisk anæmi, kronisk hæmolytisk anæmi, neonatal hyperbilirubinæmi eller ved fravær af kliniske symptomer </li> <li>Sygdommen er sjældent fatal</li> </ul> <h3>Forekomst</h3> <ul> <li>G6PD-mangel forekommer med stigende hyppighed i Afrika, Asien og Middelhavslandene</li> <li>G6PD-mangel er overordentligt udbredt, over 400 millioner menes at bære et sygt gen </li> <li>Prævalens af tilstanden er korreleret med den geografiske (historiske) udbredelse af malaria. Dette har ført til en teori om, at bærere af G6PD-mangel har en delvis beskyttelse mod malariainfektion </li> <li>Tilfælde af sporadiske genmutationer forekommer i alle populationer</li> </ul> <h3>Ætiologi og patogenese</h3> <h4>Patofysiologi</h4> <p><img src="65DC5CCAB239442A988091DDF1364DB5-240-120" style="height: 120px; width: 240px;" alt="pentose phosphate pathway." height="120" width="240"></p> <ul> <li>Jvf. figuren : </li> <li>G6PD katalyserer NADP til sin reducerede form NADPH i pentosefosfat-metabolismen </li> <li>NADPH beskytter celler mod oxidativ skade </li> <li>Fordi erytrocytter ikke danner NADPH på nogen anden måde<a href="%20" title="WHO Working Group, Glucose-6-phosphate dehydrogenase deficiency. Bull World Health Organ 1989;67: 601-11" data-url="reference-link" data-value-piped="WHO Working Group|Glucose-6-phosphate dehydrogenase deficiency|Bull World Health Organ|1989|67|601-11" data-value="WHO Working Group, Glucose-6-phosphate dehydrogenase deficiency. Bull World Health Organ 1989;67: 601-11" data-type="journal-reference"><sup>9</sup></a>, er de mere udsatte for ødelæggelse af oxidativt stress end andre celler </li> <li>Niveauet af G6PD-aktiviteten i afficerede erytrocytter er generelt lavere end i andre celler </li> <li>Normale røde blodceller, som ikke er under oxidativt stress, udviser en G6PD-aktivitet på ca. 2 % af sin totale kapacitet </li> <li>Selv ved væsentlig reduceret enzymaktivitet kan der være få eller ingen kliniske symptomer </li> <li>En total mangel på G6PD er uforenelig med liv </li> <li>Forskellige varianter af G6PD-mangel inddeles i forskellige klasser afhængig af sygdommens sværhedsgrad<a href="%20" title="Gregg XT, Prchal JT. Red cell enzymopathies. In: Hoffman R, ed. Hematology: basic principles and practice. 4th ed. Philadelphia: Churchill Livingstone; 2000; 657-60" data-url="reference-link" data-value-piped="Gregg XT, Prchal JT|Red cell enzymopathies. In: Hoffman R, ed. Hematology: basic principles and practice. 4th ed| Philadelphia|Churchill Livingstone|2000; 657-60" data-value="Gregg XT, Prchal JT. Red cell enzymopathies. In: Hoffman R, ed. Hematology: basic principles and practice. 4th ed. Philadelphia: Churchill Livingstone; 2000; 657-60" data-type="book-reference"><sup>10</sup></a></li> </ul> <h4>Genetik</h4> <ul> <li>Genmutationerne, som påvirker kodningen af G6PD, findes på den lange arm af X-kromosomet </li> <li>Mere end 200 mutationer er identificeret<a href=" " data-type="journal-reference" data-value="Bizzarro MJ, Colson E, Ehrenkranz RA, Differential diagnosis and management of anemia in the newborn. Pediatr Clin North Am 2004;51: 1087-107, xi" data-value-piped="Bizzarro MJ, Colson E, Ehrenkranz RA|Differential diagnosis and management of anemia in the newborn.|Pediatr Clin North Am|2004|51|1087-107, xi|15275990" data-url="reference-link" data-pubmedid="15275990" title="Bizzarro MJ, Colson E, Ehrenkranz RA, Differential diagnosis and management of anemia in the newborn. Pediatr Clin North Am 2004;51: 1087-107, xi"><sup>4</sup></a> </li> <li>De fleste varianter optræder sporadiske, selv om G6PD-Middelhav og G6PD A-varianterne forekommer med øget hyppighed i visse populationer</li> </ul> <h3>Disponerende faktorer</h3> <ul> <li>Arv </li> </ul> <h3>ICPC-2</h3> [ICPC] <h3>ICD-10/SKS-koder</h3> <p>[ICD10]</p> <h2>Link til vejledninger</h2> <ul> <li><a rel="noopener noreferrer" href="https://view.officeapps.live.com/op/view.aspx?src=https%3A%2F%2Fbenign.dk%2Fwp-content%2Fuploads%2F2024%2F01%2FG6PD-Medicinliste.docx&wdOrigin=BROWSELINK" target="_blank">Lægemidler som bør undgås ved kendt G6PD mangel</a></li> <li>Forløbsbeskrivelser og regionale pakkeforløb [ICPC]</li> </ul>]]></HtmlField> <HtmlField Name="Resume"><![CDATA[<h2>Resumé</h2> <h4> Diagnose </h4> <ul> <li>G6PD mangel er en X bundet arvelig tilstand, som primært ses hos indvandrere (mænd) og som disponerer til hæmolytisk anæmi, såfremt erytrocytterne udsættes for visse fødevarer (favabønner) eller lægemidler som kan medføre oxidativt stress</li> <li>Diagnosen stilles ved blodprøve med påvisning af nedsat enzymaktivitet, som dog under en episode med kraftig hæmolyse (navnlig hvis der er givet blodtransfusion) kan være falsk negativ</li> </ul> <h4> Behandling </h4> <ul> <li>Undgå lægemidler og fødevarer, som kan medføre hæmolytiske kriser</li> <li>Blodtransfusioner ved sværere hæmolysetilfælde</li> <li>Hæmolysen er selvlimiterende, men kan blive livstruende. Ophører når eksposition for det udløsende agens ophører</li> </ul> <h4> Henvisning </h4> <ul> <li>Patienter med indvandrerbaggrund fra navnlig Mellemøsten, Afrika og Asien kan tilbydes udredning</li> <li>Eftersom sygdommen er X bundet ses den primært hos mænd, men i højendemiske områder kan allelfrekvensen være så hyppig, at også kvinder kan være afficerede</li> </ul>]]></HtmlField> <LinkListField Name="Spot2"> <LinkField linktype="internal">{99A85AFD-2F7A-4B5D-A1C9-C2701D5E7D30}</LinkField> </LinkListField> <TextField Name="DoctorsHandbookID">15850</TextField> <TextField Name="PageTitle">G6PD mangel</TextField> <TextField Name="NavigationTitle">G6PD mangel</TextField> <CheckBoxField Name="ShowInMenu">true</CheckBoxField> <CheckBoxField Name="ShowInContentField">true</CheckBoxField> <DateTimeField Name="RevisedDate">2024-12-16T10:25:00</DateTimeField> <LinkListField Name="Authors"> <LinkField linktype="internal">{3F7E8AE9-7C01-42F5-94B0-FD46B72E9547}</LinkField> <LinkField linktype="internal">{FDEF4DBD-AAF0-4AF0-82F7-983F8710B93E}</LinkField> </LinkListField> <LinkListField Name="Organization"> <LinkField linktype="internal">{CF77E8B9-9937-42B2-85DF-76B0F4E401F0}</LinkField> </LinkListField> <TextField Name="ICD10">D55, D55.0</TextField> <TextField Name="ICPC2">B78</TextField> <LinkListField Name="SearchAreaID"> <LinkField linktype="internal">2</LinkField> </LinkListField> <TextField Name="Description">Glucose-6-phosphate dehydrogenase (G6PD) mangel er en medfødt hæmolytisk anæmi. Det er en tilstand, som øger erytrocytternes sårbarhed overfor oxidativt stress.</TextField> <LinkListField Name="LHPHEditor"> <LinkField linktype="internal">{C70DFB71-BE40-455A-BD6B-5AFF199797D9}</LinkField> </LinkListField> <TextField Name="__Updated by">sitecore\kack</TextField> <TextField Name="MetaKeywords">g6pd-mangel, glukose-6-fosfat dehydrogenase (g6pd) mangel, glukose-6-fosfat dehydrogenase, hæmolytisk anemi, G6PD mangel</TextField> <LinkListField Name="InformationCategory"> <LinkField linktype="internal">IC_13</LinkField> </LinkListField> <LinkListField Name="InformationType"> <LinkField linktype="internal">7</LinkField> </LinkListField> <LinkListField Name="SearchTargetGroup"> <LinkField linktype="internal">2</LinkField> </LinkListField> </Content> <Medias> <Media Id="65DC5CCAB239442A988091DDF1364DB5-240-120" Name="pentose phosphate pathway" MimeType="image/jpeg" Extension="jpg" Width="350" Height="175"><![CDATA[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]]></Media> </Medias> </Item> </Provider>
65.632 characters